Markus Hahn

2.0k citations

73 papers · 871 indexed · h-index 17

Impact in

Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Obstetrics and Gynecology top 5%
- Uterine Myomas and Treatments
- Gynecological conditions and treatments

Papers in ⓘ

Cancer Research 35
- Breast Cancer Treatment Studies 31
- Cancer Genomics and Diagnostics 7
Oncology 34
- Cancer Cells and Metastasis 17
- HER2/EGFR in Cancer Research 5

Co-authors: Sara Y. Brucker (33 shared papers)Andreas D. Hartkopf (35 shared papers)Tanja Fehm (16 shared papers)D. Wallwiener (21 shared papers)Markus Wallwiener (22 shared papers)Florin‐Andrei Taran (16 shared papers)Ines Gruber (14 shared papers)Annette Staebler (11 shared papers)
Journals: Archives of Gynecology and Obstetrics (8 papers)Breast Cancer Research and Treatment (7 papers)Ultraschall in der Medizin - European Journal of Ultrasound (5 papers)Cancers (4 papers)Journal of Clinical Oncology (3 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Markus Hahn

61 papers receiving 856 citations

Peers

Countries citing papers authored by Markus Hahn

Since Specialization

Citations

This map shows the geographic impact of Markus Hahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hahn more than expected).

Fields of papers citing papers by Markus Hahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Hahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hahn. The network helps show where Markus Hahn may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Hahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Hahn Line = papers co-authored together Markus Hahn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Targeted imaging of bacterial infections: advances, hurdles and hopes FEMS Microbiology Reviews ·Marleen van Oosten, Markus Hahn, Lucia M.A. Crane, Rick G. Pleijhuis, Kevin P. Francis, Jan Maarten van Dijl, Gooitzen M. van Dam	2015	109
2	Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer. PubMed ·Ines Gruber, N Landenberger, Annette Staebler, Markus Hahn, D. Wallwiener, Tanja Fehm	2013	58
3	Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients – Results from a large single-centre analysis European Journal of Cancer ·Andreas D. Hartkopf, Florin‐Andrei Taran, Markus Wallwiener, Markus Hahn, Sven Becker, Erich‐Franz Solomayer, Sara Y. Brucker, Tanja Fehm, D. Wallwiener	2014	52
4	Laparoscopic radiofrequency volumetric thermal ablation of fibroids versus laparoscopic myomectomy International Journal of Gynecology & Obstetrics ·Sara Y. Brucker, Markus Hahn, Dorit Kraemer, Florin‐Andrei Taran, Keith Isaacson, Bernhard Krämer	2014	51
5	HER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumor. PubMed ·Natalia Krawczyk, Małgorzata Banyś, Hans Neubauer, Erich‐Franz Solomayer, Christian Gall, Markus Hahn, Sven Becker, Robert Bachmann, D. Wallwiener, Tanja Fehm	2009	48
6	Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse Annals of Oncology ·Andreas D. Hartkopf, Markus Wallwiener, Tanja Fehm, Markus Hahn, Christina Barbara Walter, Ines Gruber, Sara Y. Brucker, Florin‐Andrei Taran	2015	32
7	Radiofrequency Volumetric Thermal Ablation of Fibroids and Laparoscopic Myomectomy: Long-Term Follow-up From a Randomized Trial Geburtshilfe und Frauenheilkunde ·Markus Hahn, Sara Y. Brucker, Dorit Kraemer, Markus Wallwiener, Florin‐Andrei Taran, Christian Wallwiener, B. Krämer	2015	30
8	Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature Archives of Gynecology and Obstetrics ·Malgorzata Banys-Paluchowski, Ines Gruber, Andreas D. Hartkopf, Peter Paluchowski, Natalia Krawczyk, Mario Marx, Sara Y. Brucker, Markus Hahn	2020	30
9	Interim analysis of a randomized controlled trial comparing laparoscopic radiofrequency volumetric thermal ablation of uterine fibroids with laparoscopic myomectomy International Journal of Gynecology & Obstetrics ·Bernhard Krämer, Markus Hahn, Florin‐Andrei Taran, Dorit Kraemer, Keith Isaacson, Sara Y. Brucker	2015	29
10	The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse Breast Cancer Research and Treatment ·Andreas D. Hartkopf, Małgorzata Banyś, F Meier-Stiegen, Markus Hahn, C Röhm, Jürgen Hoffmann, G Helms, Florin‐Andrei Taran, Markus Wallwiener, Christina B. Walter, Hans Neubauer, D. Wallwiener, Tanja Fehm	2013	27
11	High intensity focused ultrasound (HIFU) for the treatment of symptomatic breast fibroadenoma International Journal of Hyperthermia ·Markus Hahn, R Fugunt, Birgitt Schoenfisch, E Oberlechner, Ines Gruber, U Hoopmann, Carmen Roehm, G Helms, Florin‐Andrei Taran, Andreas D. Hartkopf, Hind Nassar Warzecha, Benjamin Wiesinger, Sara Y. Brucker, B Böer	2018	23
12	Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients BMC Cancer ·Natalia Krawczyk, Andreas D. Hartkopf, Małgorzata Banyś, F Meier-Stiegen, Annette Staebler, Markus Wallwiener, C Röhm, Juergen Hoffmann, Markus Hahn, Tanja Fehm	2014	22
13	Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situ Breast Cancer Research and Treatment ·Małgorzata Banyś, Markus Hahn, Ines Gruber, Natalia Krawczyk, Markus Wallwiener, Andreas D. Hartkopf, Florin‐Andrei Taran, C Röhm, Ralf Kurth, Sven Becker, Erich‐Franz Solomayer, D. Wallwiener, Annette Staebler, Tanja Fehm	2014	21
14	Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients Cancer Research and Treatment ·Andreas D. Hartkopf, Markus Wallwiener, Markus Hahn, Tanja Fehm, Sara Y. Brucker, Florin‐Andrei Taran	2015	20
15	Relationship Between Hematogenous Tumor Cell Dissemination and Cellular Immunity in DCIS Patients. PubMed ·Ines Gruber, Andreas D. Hartkopf, Markus Hahn, Florin‐Andrei Taran, Annette Staebler, D. Wallwiener, Sara Y. Brucker, Julia Hanke, Tanja Fehm	2016	17
16	Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer Breast Cancer Research and Treatment ·Andreas D. Hartkopf, Diana Stefanescu, Markus Wallwiener, Markus Hahn, Sven Becker, Erich‐Franz Solomayer, Tanja Fehm, Sara Y. Brucker, Florin‐Andrei Taran	2014	16
17	Naming the Barriers between Anti-CCR5 Therapy, Breast Cancer and Its Microenvironment International Journal of Molecular Sciences ·Elizabeth A. Brett, Dominik Duscher, Andrea Pagani, Adrien Daigeler, Jonas Kolbenschlag, Markus Hahn	2022	16
18	Feasibility of Adjuvant Treatment with Abemaciclib—Real-World Data from a Large German Breast Center Journal of Personalized Medicine ·Dominik Dannehl, Léa L. Volmer, Martin Weiß, Sabine Matovina, Eva‐Maria Grischke, E Oberlechner, Anna Seller, Christina Barbara Walter, Markus Hahn, Tobias Engler, Sara Y. Brucker, Andreas D. Hartkopf	2022	16
19	Sonographic Criteria for the Confirmation of Implant Rotation and the Development of an Implant-Capsule-Interaction (”Interface”) in Anatomically Formed Textured Breast Implants with Texturised Biocell®-Surface Ultraschall in der Medizin - European Journal of Ultrasound ·Markus Hahn, Rohini Kuner, P. Scheler, Klaus Freidel, G. M. Hoffmann, H. Madjar, D. Wallwiener, U. Krainick‐Strobel	2007	15
20	Disseminated tumor cells as a monitoring tool for adjuvant therapy in patients with primary breast cancer Breast Cancer Research and Treatment ·Ines Gruber, Tanja Fehm, Florin‐Andrei Taran, Markus Wallwiener, Markus Hahn, D. Wallwiener, Natalia Krawzyck, Juergen Hoffmann, Andreas D. Hartkopf	2014	15

About Markus Hahn

Markus Hahn is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Surgery and Pulmonary and Respiratory Medicine, having authored 73 papers that have together received 871 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (31 papers), Breast Lesions and Carcinomas (21 papers), Cancer Cells and Metastasis (17 papers), Breast Implant and Reconstruction (8 papers), Cancer Genomics and Diagnostics (7 papers), Uterine Myomas and Treatments (6 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer and Skin Lesions (4 papers). The work is most often cited by research in Cancer Research (338 citations), Obstetrics and Gynecology (121 citations), Oncology (405 citations), Reproductive Medicine (101 citations) and Pathology and Forensic Medicine (127 citations). Markus Hahn has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Sara Y. Brucker, Andreas D. Hartkopf, Tanja Fehm, D. Wallwiener, Markus Wallwiener, Florin‐Andrei Taran, Ines Gruber, Annette Staebler, Lucia M.A. Crane and Marleen van Oosten. Their work appears in journals such as Archives of Gynecology and Obstetrics, Breast Cancer Research and Treatment, Ultraschall in der Medizin - European Journal of Ultrasound, Cancers and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact